PMN - ProMIS Neurosciences Inc. Common Shares (ON)

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.47 0.01 (1.64%) --- 0.0 (0.0%) 0.0 (0.0%) 0.01 (2.35%) -0.02 (-4.17%) 0.01 (1.97%) 0.01 (1.97%)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.21
Diluted EPS:
-0.21
Basic P/E:
-2.27
Diluted P/E:
-2.27
RSI(14) 1m:
100.0
VWAP:
0.48
RVol:

Events

Period Kind Movement Occurred At

Related News